[Cycloplatin (LACHEMA) in ovarian carcinoma. Results of a registered study].

Abstract

A short report is given on the first results of the Carboplatin registration trial in ovarian cancer. CR 3/10 pat. PR 4/10 pat. remission time 10 ms in average. In comparison with cisplatin the efficacy is similar. The side effects are different particularly the bone marrow was more affected in contrast to cisplatin. The nephrotoxic side effects can be neglected.

• Authors: W Krafft, U Müller, J Hoffmann, H Nöschel, J Schloser, E M König, R Lorenz
• Journal: Zentralblatt fur Gynakologie (Zentralbl Gynakol) Vol. 112 Issue 23 Pg. 1463-7 ( 1990) ISSN: 0044-4197 [Print] Germany
• Vernacular Title: Cycloplatin (LACHEMA) beim Ovarialkarzinom. Ergebnisse einer Registrierungsstudie.
• PMID: 2291370 (Publication Type: Clinical Trial, English Abstract, Journal Article)

Chemical References

• Carboplatin

Topics

• Adult
• Aged
• Carboplatin (administration & dosage, pharmacokinetics, therapeutic use)
• Female
• Humans
• Middle Aged
• Ovarian Neoplasms (drug therapy)